Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qiping Feng

Showing results (71-80 of 115) with videos related to

Pageof 12
Sort By:
Lupus|May 12, 2021
Pleiotropy of systemic lupus erythematosus risk alleles and cardiometabolic disorders: A phenome-wide association study and inverse-variance weighted meta-analysisVivian K Kawai, Mingjian Shi, Ge Liu, et al.
Plos Medicine|August 29, 2018
Relationship between very low low-density lipoprotein cholesterol concentrations not due to statin therapy and risk of type 2 diabetes: A US-based cross-sectional observational study using electronic health recordsQiPing Feng, Wei-Qi Wei, Cecilia P Chung, et al.
Clinical and Translational Science|May 30, 2025
PTPN2 and Leukopenia in Individuals With Normal TPMT and NUDT15 Metabolizer Status Taking AzathioprineLaura L Daniel, Puran Nepal, Jacy Zanussi, et al.
JAMA Network Open|June 7, 2021
A Mendelian Randomization Approach Using 3-HMG-Coenzyme-A Reductase Gene Variation to Evaluate the Association of Statin-Induced Low-Density Lipoprotein Cholesterol Lowering With Noncardiovascular Disease PhenotypesGe Liu, Mingjian Shi, Jonathan D Mosley, et al.
Research Square|May 25, 2026
Integrating genetically predicted transcriptomic signatures with longitudinal real-world data enables scalable drug repurposing for Alzheimer's diseaseMonika E Grabowska, Rui Chen, Ying Zhou, et al.
Nature Communications|September 9, 2023
Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanismsMilton Pividori, Sumei Lu, Binglan Li, et al.
Journal of Biomedical Informatics|December 14, 2020
A retrospective approach to evaluating potential adverse outcomes associated with delay of procedures for cardiovascular and cancer-related diagnoses in the context of COVID-19Neil S Zheng, Jeremy L Warner, Travis J Osterman, et al.
Clinical Pharmacology and Therapeutics|September 28, 2021
TPMT and NUDT15 Variants Predict Discontinuation of Azathioprine for Myelotoxicity in Patients with Inflammatory Disease: Real-World Clinical ResultsAlyson L Dickson, Laura L Daniel, Jacy Zanussi, et al.
Research Square|January 10, 2024
Genetic and Survey Data Improves Performance of Machine Learning Model for Long COVIDWei-Qi Wei, Christopher Guardo, Srushti Gandireddy, et al.
Clinical Pharmacology and Therapeutics|July 23, 2025
RAB19, SERPINB9P1, and Pancreatitis in Patients Taking Azathioprine in Routine Clinical Practice: Genome and Transcriptome-Wide Association StudiesShailja C Shah, Tyler S Reese, Laura L Daniel, et al.
Pageof 12

Showing results (71-80 of 115) with videos related to

Sort By:
Pageof 12
Lupus|May 12, 2021
Pleiotropy of systemic lupus erythematosus risk alleles and cardiometabolic disorders: A phenome-wide association study and inverse-variance weighted meta-analysisVivian K Kawai, Mingjian Shi, Ge Liu, et al.
Plos Medicine|August 29, 2018
Relationship between very low low-density lipoprotein cholesterol concentrations not due to statin therapy and risk of type 2 diabetes: A US-based cross-sectional observational study using electronic health recordsQiPing Feng, Wei-Qi Wei, Cecilia P Chung, et al.
Clinical and Translational Science|May 30, 2025
PTPN2 and Leukopenia in Individuals With Normal TPMT and NUDT15 Metabolizer Status Taking AzathioprineLaura L Daniel, Puran Nepal, Jacy Zanussi, et al.
JAMA Network Open|June 7, 2021
A Mendelian Randomization Approach Using 3-HMG-Coenzyme-A Reductase Gene Variation to Evaluate the Association of Statin-Induced Low-Density Lipoprotein Cholesterol Lowering With Noncardiovascular Disease PhenotypesGe Liu, Mingjian Shi, Jonathan D Mosley, et al.
Research Square|May 25, 2026
Integrating genetically predicted transcriptomic signatures with longitudinal real-world data enables scalable drug repurposing for Alzheimer's diseaseMonika E Grabowska, Rui Chen, Ying Zhou, et al.
Nature Communications|September 9, 2023
Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanismsMilton Pividori, Sumei Lu, Binglan Li, et al.
Journal of Biomedical Informatics|December 14, 2020
A retrospective approach to evaluating potential adverse outcomes associated with delay of procedures for cardiovascular and cancer-related diagnoses in the context of COVID-19Neil S Zheng, Jeremy L Warner, Travis J Osterman, et al.
Clinical Pharmacology and Therapeutics|September 28, 2021
TPMT and NUDT15 Variants Predict Discontinuation of Azathioprine for Myelotoxicity in Patients with Inflammatory Disease: Real-World Clinical ResultsAlyson L Dickson, Laura L Daniel, Jacy Zanussi, et al.
Research Square|January 10, 2024
Genetic and Survey Data Improves Performance of Machine Learning Model for Long COVIDWei-Qi Wei, Christopher Guardo, Srushti Gandireddy, et al.
Clinical Pharmacology and Therapeutics|July 23, 2025
RAB19, SERPINB9P1, and Pancreatitis in Patients Taking Azathioprine in Routine Clinical Practice: Genome and Transcriptome-Wide Association StudiesShailja C Shah, Tyler S Reese, Laura L Daniel, et al.
Pageof 12